Investment Rating - The report maintains a "Buy" investment rating for China National Offshore Oil Corporation (CNOOC) [1] Core Views - CNOOC achieved record high oil and gas production and reserves in 2024, with a total production of 727 million barrels of oil equivalent, representing a year-on-year increase of 7.2% [5] - The company has demonstrated strong cost control, with the average oil equivalent cost decreasing to $28.52 per barrel, maintaining a competitive edge in profitability [5] - CNOOC's capital expenditure for 2024 reached RMB 132.7 billion, aimed at sustaining production growth and infrastructure investment [6][7] - The company has shown resilience against external challenges, maintaining stable operations and proposing a dividend of HKD 0.66 per share for 2024 [8] - Profit forecasts for 2025-2027 indicate a steady growth in net profit, with estimates of RMB 150 billion, RMB 159.7 billion, and RMB 173.1 billion respectively [9] Summary by Sections Market Performance - CNOOC's stock price is currently at RMB 24.34, with a market capitalization of RMB 115.69 billion [1] Financial Highlights - In 2024, CNOOC reported total revenue of RMB 420.51 billion, a year-on-year increase of 0.94%, and a net profit of RMB 137.94 billion, up 11.38% from the previous year [4] Production and Cost Management - The company achieved a total oil and gas production of 727 million barrels of oil equivalent, with a sales volume of 563 million barrels, reflecting a 9.4% increase in demand [5] - The average realized oil price was $76.75 per barrel, a decrease of approximately 1.6% year-on-year, while the average realized natural gas price was $7.72 per thousand cubic feet, down 3.3% [5] Capital Expenditure and Future Outlook - CNOOC plans to maintain a capital expenditure level similar to 2024 to support production growth, with a target production of 760 to 780 million barrels of oil equivalent for 2025 [7] Profitability and Shareholder Returns - The company aims to maintain a dividend payout ratio of no less than 45% from 2025 to 2027, enhancing shareholder returns [8]

2025 年 04 月 09 日 利润边际修复，成本低位企稳 买入(维持) 事件 | 分析师：孙山山 | S1050521110005 | | --- | --- | | sunss@cfsc.com.cn | | | 联系人：张倩 | S1050124070037 | | zhangqian@cfsc.com.cn | | | 基本数据 | 2025-04-08 | | --- | --- | | 当前股价（元） | 11.59 | | 总市值（亿元） | 56 | | 总股本（百万股） | 483 | | 流通股本（百万股） | 398 | | 52 周价格范围（元） | 7-11.59 | | 日均成交额（百万元） | 71.37 | 市场表现 -50 -40 -30 -20 -10 0 10 20 30 (%) 晨光生物 沪深300 资料来源：Wind，华鑫证券研究 相关研究 1、《晨光生物（300138）：营收规 模边际增长，计提资产减值损失致 使亏损》2024-10-27 2、《晨光生物（300138）：价格下 跌共振拖累经营，主业市占率延续 提升》2024-08-28 3、《晨光生物（30013 ...

2025 年 04 月 09 日 营收边际提速，渠道变革持续推进 —中炬高新（600872.SH）公司事件点评报告 买入(维持) 事件 | 分析师：孙山山 | S1050521110005 | | --- | --- | | sunss@cfsc.com.cn | | | 联系人：张倩 | S1050124070037 | | zhangqian@cfsc.com.cn | | | 基本数据 | 2025-04-08 | | --- | --- | | 当前股价（元） | 19.89 | | 总市值（亿元） | 156 | | 总股本（百万股） | 783 | | 流通股本（百万股） | 771 | | 52 周价格范围（元） | 16.25-29.92 | | 日均成交额（百万元） | 292.21 | 市场表现 -50 -40 -30 -20 -10 0 10 20 30 (%) 中炬高新 沪深300 资料来源：Wind，华鑫证券研究 相关研究 1、《中炬高新（600872）：降本增 效持续推进，盈利能力同比提升》 2025-01-24 2、《中炬高新（600872）：无偿受 让少数股权，增厚公司利润表现 ...

2025 年 04 月 09 日 营收边际提速，渠道变革持续推进 —中炬高新（600872.SH）公司事件点评报告 买入(维持) 事件 | 分析师：孙山山 | S1050521110005 | | --- | --- | | sunss@cfsc.com.cn | | | 联系人：张倩 | S1050124070037 | | zhangqian@cfsc.com.cn | | | 基本数据 | 2025-04-08 | | --- | --- | | 当前股价（元） | 19.89 | | 总市值（亿元） | 156 | | 总股本（百万股） | 783 | | 流通股本（百万股） | 771 | | 52 周价格范围（元） | 16.25-29.92 | | 日均成交额（百万元） | 292.21 | 市场表现 -50 -40 -30 -20 -10 0 10 20 30 (%) 中炬高新 沪深300 资料来源：Wind，华鑫证券研究 相关研究 1、《中炬高新（600872）：降本增 效持续推进，盈利能力同比提升》 2025-01-24 2、《中炬高新（600872）：无偿受 让少数股权，增厚公司利润表现 ...

Investment Rating - The report assigns a "Buy" rating for the company, marking the first coverage of the stock [2][10]. Core Insights - The company is positioned to benefit from the growth in the domestic instrumentation and automation industry, driven by policy support and high demand from downstream sectors such as petrochemicals and power [5]. - The company has a comprehensive product line and has made significant advancements in R&D, with a notable increase in new automation solutions and patents [6]. - The company is accelerating its global expansion, with a significant increase in export revenue and new orders, particularly in emerging markets [7][9]. Summary by Sections Market Performance - The company's stock price is currently at 21.88 CNY, with a total market capitalization of 112 billion CNY and a 52-week price range of 15.76 to 28.29 CNY [2]. Industry Dynamics - The instrumentation and automation industry in China reached a market size of 1.08 trillion CNY in 2024, with a year-on-year growth of 4.3% [5]. - The domestic brands in the control valve industry accounted for 44.38% of the sales in 2022, indicating a strong trend towards domestic substitution [5]. Competitive Advantages - The company has invested 2.64 billion CNY in R&D in the first half of 2024, reflecting a 4.67% increase year-on-year, with a R&D expense ratio of 7.05% [6]. - The company has established a strategic partnership with China National Machinery Group, enhancing its market influence and resource integration [6]. Financial Forecast - Revenue projections for 2024, 2025, and 2026 are 79.24 billion CNY, 88.22 billion CNY, and 100.92 billion CNY, respectively, with corresponding EPS of 1.57 CNY, 1.77 CNY, and 2.07 CNY [10][12]. - The company is expected to maintain a strong growth trajectory, benefiting from technological advancements, capacity expansion, and international market penetration [10].

Investment Rating - The report assigns a "Buy" rating for the company, marking the first coverage of the stock [2][10]. Core Insights - The company is positioned to benefit from the growth in the domestic instrumentation and automation industry, driven by policy support and high demand from downstream sectors such as petrochemicals and power [5]. - The company has a comprehensive product line and has made significant advancements in R&D, with a notable increase in new automation solutions and patents [6]. - The company is accelerating its global expansion, with a significant increase in export revenue and new orders, particularly in emerging markets [7][9]. Summary by Sections Market Performance - The company's stock price is currently at 21.88 CNY, with a total market capitalization of 112 billion CNY and a 52-week price range of 15.76 to 28.29 CNY [2]. Industry Dynamics - The instrumentation and automation industry in China reached a market size of 1.08 trillion CNY in 2024, showing a year-on-year growth of 4.3% [5]. - The domestic brands in the control valve industry accounted for 44.38% of the sales in 2022, indicating a strong trend towards domestic substitution [5]. Technological Development - The company invested 264 million CNY in R&D in the first half of 2024, representing a year-on-year increase of 4.67%, with a R&D expense ratio of 7.05% [6]. - The company has participated in the formulation of national and industry standards and has obtained 92 new patents during the reporting period [6]. Financial Forecast - Revenue projections for 2024, 2025, and 2026 are 79.24 billion CNY, 88.22 billion CNY, and 100.92 billion CNY, respectively, with corresponding EPS of 1.57 CNY, 1.77 CNY, and 2.07 CNY [10][12]. - The company is expected to maintain a strong growth trajectory, with a projected net profit growth rate of 28.5% in 2023 and 16.6% in 2026 [12].

2025 年 04 月 09 日 双融日报 --鑫融讯 分析师：万蓉 S1050511020001 wanrong@cfsc.com.cn 市场情绪：51 分（中性） ▌ 华鑫市场情绪温度指标：（中性） 华鑫市场情绪温度指标显示，昨日市场情绪综合评分为 51 分，市场情绪处于"中性"。历史市场情绪趋势变化可参 考图表 1。 ▌ 热点主题追踪 今日热点主题：医疗器械、脑机接口、AI 1、医疗器械主题：国家药监局公开征求《关于优化全生 命周期监管 支持高端医疗器械创新发展的举措（征求意见 稿）》意见。加快发布医用外骨骼机器人、放射性核素成像 设备等相关标准。加快推进医用机器人、人工智能医疗器 械、高端医学影像设备等领域的基础、通用标准和方法标准 等制修订工作。相关标的：联影医疗（688271）、迈瑞医疗 （300760） 2、脑机接口主题：3 月 31 日，在 2025 中关村论坛年会 举行的脑机接口创新发展与应用论坛上，工业和信息化部科 技司相关人员表示，人工智能技术的快速演进正在推动脑机 接口等面向未来的智能技术和产品加速推进。接下来，工信 部将加强顶层设计，与有关部门加强协同，发布《关于推动 脑机接口产业创 ...

2025 年 04 月 09 日 优质内容促内需 横店具品牌优势 —横店影视（603103.SH）公司动态研究报告 买入(维持) 投资要点 分析师：朱珠 S1050521110001 zhuzhu@cfsc.com.cn | 基本数据 | 2 0 2 5-0 4-0 8 | | --- | --- | | 当前股价（元） | 13.83 | | 总市值（亿元） | 88 | | 总股本（百万股） | 634 | | 流通股本（百万股） | 634 | | 52 周价格范围（元） | 9.81-17.14 | | 日均成交额（百万元） | 81.18 | 市场表现 -40 -30 -20 -10 0 10 20 30 (%) 横店影视 沪深300 资料来源：Wind，华鑫证券研究 相关研究 1、《横店影视（603103）：2024 年 业绩承压落地看 2025 年内容新供 给》2025-01-18 2、《横店影视（603103）：2024 年 跨越低谷新增可期内容需求韧性持 续》2024-03-08 3、《横店影视（603103）：2023Q4 承压落地 2024 年跨越低谷新增可 期》2024-01-29 预 ...

Investment Rating - The report assigns a "Buy" investment rating for the company, indicating a positive outlook for future performance [9]. Core Insights - The company's performance is under pressure due to a decrease in customer demand for metal extraction agents, which significantly impacts revenue [5]. - Despite the challenges, the company is enhancing its research capabilities and has initiated a share buyback plan, reflecting confidence in future growth [6][7]. - The importance of the company's metal extraction agents in the recycling of power batteries is expected to increase as the electric vehicle market evolves [9]. Financial Performance - In 2024, the company reported total revenue of 330 million yuan, a decline of 25.21% year-on-year, with a net profit of 80 million yuan, down 46.39% [4]. - The metal extraction agent segment generated 279 million yuan in revenue, accounting for 84.36% of total revenue, but saw a 31.97% decline due to reduced demand [5]. - The company’s other specialty surfactants contributed 51 million yuan in revenue, showing a growth of 60.92%, partially offsetting the decline in metal extraction agent revenue [5]. Expense Trends - The company experienced an increase in various expense ratios, particularly in management and research and development, due to the establishment of a new research institute and hiring of skilled personnel [6]. - The net cash flow from operating activities was negative 9 million yuan, primarily due to delayed customer payments [6]. Future Projections - Forecasts for the company's net profit for 2025, 2026, and 2027 are 132 million yuan, 162 million yuan, and 142 million yuan respectively, with corresponding price-to-earnings ratios of 14.8, 12.0, and 13.7 [9][11].

| 表现 | 1M | 3M | 12M | | --- | --- | --- | --- | | 计算机(申万) | -23.8 | 0.7 | 12.5 | | 沪深 300 | -9.0 | -5.3 | 1.5 | 2025 年 04 月 08 日 Llama 4 多版本参数亮眼，DeepSeek 公布推理 时 Scaling 新论文 推荐(维持) 投资要点 分析师：宝幼琛 S1050521110002 baoyc@cfsc.com.cn 行业相对表现 市场表现 -40 -20 0 20 40 60 (%) 计算机 沪深300 资料来源：Wind，华鑫证券研究 相关研究 1、《计算机行业周报：阿里深夜开 源Qwen2.5-Omni，DeepSeek-V3上线 新版本》2025-04-05 2、《计算机行业点评报告：文远知 行（WRD.O）：收入承压与商业化突 破并行，自动驾驶长赛道静待拐 点》2025-04-04 3、《计算机行业点评报告：禾赛科 技（HSAI.O）：激光雷达龙头加速 业绩兑现，多元布局打开成长空 间》2025-04-04 ▌算力： Llama 4 多版本参数亮眼，2 万亿多模态巨 ...